Long-Term Benefit–Risk Profiles of Treatments for Moderate-to-Severe Plaque Psoriasis: A Network Meta-Analysis

被引：0
|
作者：
April W. Armstrong
Ahmed M. Soliman
Keith A. Betts
Yan Wang
Yawen Gao
Vassilis Stakias
Luis Puig
机构：
[1] University of Southern California,Department of Dermatology, Keck School of Medicine
[2] AbbVie,Department of Dermatology, Hospital de la Santa Creu i Sant Pau
[3] Inc.,undefined
[4] Analysis Group,undefined
[5] Inc.,undefined
[6] AbbVie,undefined
[7] Inc.,undefined
[8] Universitat Autònoma de Barcelona,undefined
来源：
Dermatology and Therapy | 2022年 / 12卷
关键词：
Long-term benefit–risk profile; Risankizumab; Bimekizumab; Ixekizumab; Network meta-analysis; Moderate-to-severe plaque psoriasis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：167 / 184
页数：17
相关论文
共 50 条
  • [1] Long-Term Benefit-Risk Profiles of Treatments for Moderate-to-Severe Plaque Psoriasis: A Network Meta-Analysis
    Armstrong, April W.
    Soliman, Ahmed M.
    Betts, Keith A.
    Wang, Yan
    Gao, Yawen
    Stakias, Vassilis
    Puig, Luis
    DERMATOLOGY AND THERAPY, 2022, 12 (01) : 167 - 184
  • [2] Letter to the Editor Regarding Long-Term Benefit–Risk Profiles of Treatments for Moderate-to-Severe Plaque Psoriasis: A Network Meta-analysis
    Dan Pettitt
    Michael Plotnick
    Joshua Gagne
    Dermatology and Therapy, 2022, 12 : 2863 - 2866
  • [3] Letter to the Editor Regarding Long-Term Benefit-Risk Profiles of Treatments for Moderate-to-Severe Plaque Psoriasis: A Network Meta-analysis
    Pettitt, Dan
    Plotnick, Michael
    Gagne, Joshua
    DERMATOLOGY AND THERAPY, 2022, 12 (12) : 2863 - 2866
  • [4] A Response to: Letter to the Editor Regarding Long-Term Benefit–Risk Profiles of Treatments for Moderate-to-Severe Plaque Psoriasis: A Network Meta-analysis
    April W. Armstrong
    Ahmed M. Soliman
    Keith A. Betts
    Yan Wang
    Yawen Gao
    Vassilis Stakias
    Luis Puig
    Dermatology and Therapy, 2022, 12 : 2867 - 2870
  • [5] A Response to: Letter to the Editor Regarding Long-Term Benefit-Risk Profiles of Treatments for Moderate-to-Severe Plaque Psoriasis: A Network Meta-analysis
    Armstrong, April W.
    Soliman, Ahmed M.
    Betts, Keith A.
    Wang, Yan
    Gao, Yawen
    Stakias, Vassilis
    Puig, Luis
    DERMATOLOGY AND THERAPY, 2022, 12 (12) : 2867 - 2870
  • [6] A network meta-analysis of long-term efficacy and safety of treatments for moderate-to-severe plaque psoriasis
    Armstrong, A.
    Soliman, A.
    Betts, K.
    Wang, Y.
    Gao, Y.
    Stakias, V.
    Puig, L.
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 186 (01) : E33 - E33
  • [7] Comparative efficacy of treatments for moderate-to-severe plaque psoriasis: An updated network meta-analysis (NMA)
    Armstrong, April W.
    Soliman, Ahmed M.
    Puig, Lluis
    Betts, Keith A.
    Wang, Yan
    Gao, Yawen
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB4 - AB4
  • [8] Efficacy and Safety of Systemic Long-Term Treatments for Moderate-to-Severe Psoriasis: A Systematic Review and Meta-Analysis
    Nast, Alexander
    Jacobs, Anja
    Rosumeck, Stefanie
    Werner, Ricardo N.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2015, 135 (11) : 2641 - 2648
  • [9] Long-term efficacy of novel therapies in moderate-to-severe plaque psoriasis: a systematic review and network meta-analysis of PASI response
    Sawyer, L. M.
    Cornic, L.
    Levin, L. A.
    Gibbons, C.
    Moller, A. H.
    Jemec, G. B.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2019, 33 (02) : 355 - 366
  • [10] Biologics for pediatric moderate-to-severe plaque psoriasis: a systematic review and network meta-analysis
    Huang, I-Hsin
    Yu, Chia-Ling
    Tai, Cheng-Chen
    Tu, Yu-Kang
    Chi, Ching-Chi
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2022, 20 (09): : 1201 - 1210
12345